Rosacea ICD‑10 Codes for Billing
Accurate medical billing for rosacea depends on selecting the correct ICD‑10 code. Dermatology practices, clinics, and hospitals must use specific codes to describe the subtype, severity, and complications of rosacea. This article provides a comprehensive guide to rosacea ICD‑10 codes, their structure, and best practices for billing and documentation. Whether you are a coder, biller, or clinician, understanding these codes ensures proper reimbursement and compliance with payer requirements.
The ICD‑10-CM (International Classification of Diseases, 10th Revision, Clinical Modification) system categorizes rosacea under “Other disorders of skin and subcutaneous tissue” (L80-L99). The primary code for unspecified rosacea is L71.9, but more specific codes exist for various presentations. Using the right code not only supports medical necessity but also minimizes claim denials and audit risks.

Key Rosacea ICD‑10 Codes
The following table lists the most commonly used ICD‑10 rosacea codes. Always review the patient’s documentation to select the most specific code.
- L71.0 – Perioral dermatitis (often considered a variant, but sometimes classified separately)
- L71.8 – Other rosacea (e.g., rosacea conglobata, rosacea fulminans)
- L71.9 – Rosacea, unspecified (most common code for typical facial redness and papules)
For rhinophyma, which is a severe form of rosacea with thickened nasal skin, use L71.1 (Rhinophyma). Note that ocular rosacea (H01.1–) is coded separately under eye disorders. When rosacea causes conjunctivitis or blepharitis, assign both the L71 code and the specific eye code.
Billing and Documentation Guidelines
Proper documentation is essential for using the correct rosacea ICD‑10 code. Clinicians should specify the subtype (erythematotelangiectatic, papulopustular, phymatous, or ocular), severity, location, and any complications. For example, “rosacea with papulopustules on cheeks” would support L71.9? Actually, if the provider documents “papulopustular rosacea,” that still falls under L71.9 because ICD‑10 does not have a separate code for subtypes. However, if it’s a rare form like rosacea conglobata, L71.8 is appropriate.
Tip: Many insurance carriers require a specific diagnosis to cover treatments like topical metronidazole or oral doxycycline. Using the unspecified code L71.9 may be appropriate for initial visits, but follow-up visits should specify the type if possible. Additionally, link the diagnosis code to the procedure code (e.g., 99213 for E&M) on the claim form.
Avoid common pitfalls: Do not use L71.9 if the patient has rhinophyma (use L71.1). For rosacea with ocular involvement, ensure both codes are reported (e.g., L71.9 and H01.119 for blepharitis). Also, be aware that some codes are for other conditions – perioral dermatitis is coded separately as L71.0, not as rosacea. When in doubt, query the provider.
Modifiers and Sequencing
In some cases, rosacea may be a comorbidity. List the primary diagnosis that prompted the encounter first. If rosacea is the reason for the visit, it should be sequenced first. For example, a patient with severe papulopustular rosacea and secondary staph infection: code the infection (L02.xx) first, then L71.9. Use appropriate modifiers (e.g., -25 for significant, separately identifiable E&M service) if applicable.
Warning: Incorrect coding can lead to claim denials or audits. For instance, using L71.9 for ocular rosacea alone will likely be rejected because the eye condition should be coded. Always verify payer-specific guidelines, as some may require more specificity (e.g., ICD‑10 2026 updates).
For billing purposes, the rosacea ICD‑10 code must be supported by the medical record. Include details such as distribution (central face, nose, cheeks, chin), presence of telangiectasias, papules, pustules, or phymatous changes. Photographs can be helpful but are not always required. Ensure that the evaluation and management (E/M) code reflects the complexity of the visit.
Common Denial Reasons and Solutions
Despite using the correct ICD‑10 rosacea code, denials can occur. Common reasons include:
- Lack of medical necessity – document impact on patient’s quality of life, failed OTC treatments, or severity.
- Code not specific enough – some carriers prefer L71.8 over L71.9 if any distinct features are documented.
- Missing modifier – for example, if a procedure is performed on the same day as the E&M visit.
To reduce denials, perform regular audits of your coding patterns. Use clear, consistent language in notes. If a claim is denied, appeal with supporting documentation, including the clinical rationale for the code choice. Keep abreast of annual ICD‑10 updates; for 2026, no major changes to rosacea codes are anticipated, but always check the latest guidelines.
Conclusion
Mastering rosacea ICD‑10 coding is crucial for successful billing and optimal patient care. By using the appropriate code – L71.9 for unspecified rosacea, L71.1 for rhinophyma, L71.8 for other specified forms, and including ocular codes when needed – you ensure accurate reimbursement and compliance. Coupled with thorough documentation and awareness of payer policies, your practice can minimize denials and focus on treating patients effectively.
For further guidance, consult your coding manual or a certified professional coder. If you have specific questions about rosacea ICD‑10 code usage, leave a comment below.